G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,009,100 | -49.1% | 370,000 | 0.0% | 0.21% | -49.2% |
Q3 2022 | $3,944,000 | +152.5% | 370,000 | +17.0% | 0.41% | +133.3% |
Q2 2022 | $1,562,000 | -35.0% | 316,137 | 0.0% | 0.18% | -25.3% |
Q1 2022 | $2,403,000 | -29.3% | 316,137 | -2.7% | 0.24% | +4.9% |
Q4 2021 | $3,400,000 | -22.1% | 325,000 | 0.0% | 0.23% | -26.1% |
Q3 2021 | $4,362,000 | -38.8% | 325,000 | 0.0% | 0.31% | -36.8% |
Q2 2021 | $7,131,000 | -8.8% | 325,000 | 0.0% | 0.48% | -11.2% |
Q1 2021 | $7,820,000 | +81.1% | 325,000 | +35.4% | 0.54% | +54.8% |
Q4 2020 | $4,318,000 | +96.7% | 240,000 | +26.3% | 0.35% | +80.5% |
Q3 2020 | $2,195,000 | -52.4% | 190,000 | 0.0% | 0.20% | -60.8% |
Q2 2020 | $4,609,000 | +67.2% | 190,000 | -24.1% | 0.50% | +29.0% |
Q1 2020 | $2,757,000 | -60.4% | 250,172 | -5.0% | 0.39% | -49.4% |
Q4 2019 | $6,962,000 | -42.9% | 263,400 | -50.8% | 0.76% | -50.1% |
Q3 2019 | $12,202,000 | +45.1% | 535,657 | +95.3% | 1.53% | +65.2% |
Q2 2019 | $8,409,000 | +138.8% | 274,274 | +29.3% | 0.93% | +124.8% |
Q1 2019 | $3,522,000 | +6.4% | 212,169 | +22.8% | 0.41% | +9.0% |
Q4 2018 | $3,310,000 | – | 172,820 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 650,000 | $3,529,500 | 0.92% |
CHI Advisors LLC | 333,945 | $1,813,321 | 0.48% |
PVG ASSET MANAGEMENT CORP | 15,585 | $84,626 | 0.37% |
Rhenman & Partners Asset Management AB | 370,000 | $2,009,100 | 0.21% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 184,000 | $999,120 | 0.18% |
Birchview Capital, LP | 40,000 | $217 | 0.15% |
XTX Topco Ltd | 102,282 | $555,391 | 0.12% |
Tekla Capital Management LLC | 423,869 | $2,301,609 | 0.09% |
Woodline Partners LP | 1,028,967 | $5,587,291 | 0.08% |
Curi Wealth Management, LLC | 81,009 | $439,879 | 0.06% |